First pancreatic cancer patient dosed in Radiopharm study

SYDNEY: Radiopharm Theranostics says it has dosed its first pancreatic cancer patient in the initial

To read the full story...SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In